Ileabett M. Vargas-Echevarria
Rio Piedras, Puerto Rico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Correction: The landscape of BRAF transcript and protein variants in human cancer.
Journal: Molecular cancer
Published: February 03, 2025
Erratum: Reduced expression of enolase-1 correlates with high intracellular glucose levels and increased senescence in cisplatin-resistant ovarian cancer cells.
Journal: American journal of translational research
Published: October 21, 2020
Reduced expression of enolase-1 correlates with high intracellular glucose levels and increased senescence in cisplatin-resistant ovarian cancer cells.
Journal: American journal of translational research
Published: January 09, 2020
COMBATING NRAS MUTANT MELANOMA: FROM BENCH TO BEDSIDE.
Journal: Melanoma management
Published: May 23, 2018
Co-targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor-resistant melanoma.
Journal: EMBO molecular medicine
Published: April 14, 2018
Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma.
Journal: Oncogene
Published: September 15, 2017
The landscape of BRAF transcript and protein variants in human cancer.
Journal: Molecular cancer
Published: October 13, 2016
Targeting miR-21-3p inhibits proliferation and invasion of ovarian cancer cells.
Journal: Oncotarget
Published: September 01, 2015
Targeting c-MYC in Platinum-Resistant Ovarian Cancer.
Journal: Molecular cancer therapeutics
Published: September 18, 2014
Upregulation of miR-21 in cisplatin resistant ovarian cancer via JNK-1/c-Jun pathway.
Journal: PloS one
Published: January 02, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026